Electric chemotherapy chair MYS-931

4-sectionon castersadjustable backrest

Product description
Meyosis Haemodialysis and Chemotherapy Chair MYS-931 is designed according to EN 60601-2-52 with a focus on patient comfort and caregiver ergonomics. Suitable for prolonged treatments, it integrates electric positioning and hygiene-oriented finishes.

General Features

• Intended for haemodialysis, oncology/chemotherapy, rehabilitation, plasmapheresis and blood transfusion procedures.
• Backrest, seat and leg-rest movements (up/down) plus Trendelenburg and reverse Trendelenburg positions are operated by 4 DC motors with a hand controller.
• Removable cramp supports and adjustable headrest (neck cushion included).
• Waterproof, easy-clean artificial leather upholstery with viscoelastic foam padding.
• 4 lockable castors for mobility and fixation.

Intended use

• Designed to provide adjustable positioning and patient comfort during haemodialysis, chemotherapy, plasmapheresis, blood transfusion, oncology treatments and rehabilitation procedures.

Technical characteristics / specifications

• Standard: Designed in accordance with EN 60601-2-52.
• Actuation: 4 DC motors controlled by a hand controller for backrest, seat and leg-rest adjustments and Trendelenburg/reverse Trendelenburg positions.
• Headrest: Adjustable headrest with included neck cushion.
• Accessories: Removable cramp supports.
• Upholstery: Waterproof, easy-clean artificial leather with viscoelastic foam padding.
• Mobility: 4 lockable castors.
• Main applications: Haemodialysis, oncology/chemotherapy, rehabilitation, plasmapheresis, blood transfusion.
• Commercial reference: MYS-931.